Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

66 та иш

Иш: Involving stemness factors to improve CAR T-cell-based cancer immunotherapy

  1. NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma

    Tobias Weiß, Michael Weller, Matthias Gückenberger +2

    Мақола20173 иқтибос
    ABI

  2. Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme

    Amir R. Afshari, Ali Motamed‐Sanaye, Hamed Sabri +7

    Мақола20213 иқтибос
    ABI

  3. Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines

    Edmund K. Moon, Liang‐Chuan S. Wang, Kheng Bekdache +4

    Мақола20172 иқтибос
    ABI

  4. Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity

    Zong Sheng Guo, Zuqiang Liu, David L. Bartlett

    Шарҳ мақола20142 иқтибос
    ABI

  5. Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies

    Shashi Gujar, Jonathan Pol, Youra Kim +2

    Шарҳ мақола20172 иқтибос
    ABI

  6. c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target

    Chenwei Li, Jingjiang Wu, Mark J. Hynes +5

    Мақола20112 иқтибос
    ABI

  7. The Emerging Role of EpCAM in Cancer and Stem Cell Signaling

    Markus Münz, Patrick A. Baeuerle, Olivier Gires

    Шарҳ мақола20092 иқтибос
    ABI

  8. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells

    Amélie Montel‐Hagen, Christopher S. Seet, Suwen Li +11

    Мақола20192 иқтибос
    ABI

  9. Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells

    Esther Drent, Renée Poels, Ruud Ruiter +9

    Мақола20192 иқтибос
    ABI

  10. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy

    Shoichi Iriguchi, Yutaka Yasui, Yohei Kawai +17

    Мақола20212 иқтибос
    ABI

  11. Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy

    Ramazan Rezaei, Hadi Esmaeili Gouvarchin Ghaleh, Mahdieh Farzanehpour +5

    Шарҳ мақола20212 иқтибос
    ABI

  12. Merkel cell carcinoma on the right calf in association with chronic lymphocytic leukemia: A case report

    Hamideh Mohammadzadeh, Sepideh Babaniamansour, Mohammadreza Majidi +3

    Мақола20212 иқтибос
    ABI

  13. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer

    Alireza Azani, Sima Parvizi Omran, Haniyeh Ghasrsaz +14

    Шарҳ мақола20232 иқтибос
    ABI

  14. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  15. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI